The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.
ALPS Medical Breakthroughs ETF SBIO
Morningstar’s Analysis SBIO
Will SBIO outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 29.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Avidity Biosciences Inc Ordinary Shares | 3.62 | 4.2 Mil | Healthcare |
Krystal Biotech Inc | 3.45 | 4.0 Mil | Healthcare |
Alkermes PLC | 3.18 | 3.7 Mil | Healthcare |
Corcept Therapeutics Inc | 3.15 | 3.6 Mil | Healthcare |
Immunovant Inc | 3.00 | 3.4 Mil | Healthcare |
Crinetics Pharmaceuticals Inc | 2.81 | 3.2 Mil | Healthcare |
Arcellx Inc | 2.79 | 3.2 Mil | Healthcare |
Denali Therapeutics Inc | 2.65 | 3.0 Mil | Healthcare |
Merus NV | 2.41 | 2.8 Mil | Healthcare |
MoonLake Immunotherapeutics Class A | 2.11 | 2.4 Mil | Healthcare |